NCT01642134View on ClinicalTrials.gov

Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI

PHASE4CompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions

Aortic Valve StenosisStroke

Interventions

DRUG

aspirin+clopidogrel (Duoplavin)

100 mg aspirin ;75 mg clopidogrel 3º months

Trial Locations (4)

20014

Policlínica de Guipuzcoa.SA, San Sebastián

36201

Hospital clinico Universitario Bellvitge, Barcelona

Hospital Clinico Universitario de Malaga, Málaga

36312

Hospital Universitario Álvaro Cunqueiro, Vigo

All Listed Sponsors

lead

Andres Iñiguez Romo, MD, PhD

OTHER_GOV

NCT01642134 - Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI | Biotech Hunter | Biotech Hunter